PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 23.22 Min. order: 1 piece ★★★★★ 4.2 (96 reviews) Sold : Login>>
Cagrilintide Combined with Semaglutide: A New Approach for Treatment of Obesity and Type 2 Diabetes US$ 26.02 Min. order: 1 piece ★★★★★ 4.0 (278 reviews) Sold : Login>>
Quarterly Drug Pipeline: April 2026 - Prime Therapeutics US$ 20.78 Min. order: 1 piece ★★★★★ 4.6 (58 reviews) Sold : Login>>
Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management - Alhomoud - 2024 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy US$ 22.92 Min. order: 1 piece ★★★★★ 4.7 (294 reviews) Sold : Login>>